RAB35 and glioblastoma: Conversely, pretreatment of astrocytes with EVs from the less invasive G7 GBM cells, or EVs from E2 cells in which either mutant p53R273H, PODXL, or Rab35 had been deleted using CRISPR, were ineffective in this regard (Figure 5B).